DOW JONES21,109.80-807.36 -3.68%
S&P 5002,482.15-102.44 -3.96%
NASDAQ7,395.60-304.50 -3.95%

Citigroup Maintains Buy on Acceleron Pharma, Lowers Price Target to $136

Citigroup maintains Acceleron Pharma (NASDAQ:XLRN) with a Buy and lowers the price target from $138 to $136.

Benzinga · 03/02/2020 13:12

Citigroup maintains Acceleron Pharma (NASDAQ:XLRN) with a Buy and lowers the price target from $138 to $136.